GlassScriptPhysician profile
Daniel Preston Pierce
NPI 1346874542
$14,622.39
in general payments reported to CMS, 2019-2025
17 companies · $3,702 in 2025
The $3,702 reported for 2025 was more than what 89% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $234 · 2022: $135 · 2023: $2,220 · 2024: $8,331 · 2025: $3,702.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $3,316 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,838.11 |
| Travel and Lodging | $3,316.19 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,350.51 | 2023-2025 | Ams 700, Spaceoar Vue System - 10ml, General - Erectile Dysfunction |
| Coloplast Corp | $5,710.73 | 2023-2025 | Titan, Altis, Speedicath |
| Janssen Biotech, INC. | $600.34 | 2024-2025 | Erleada, Carvykti, Rybrevant |
| Angiodynamics, INC. | $238.82 | 2023-2025 | Nanoknife |
| Axogen | $232.78 | 2025 | |
| Urogen Pharma, INC. | $193.01 | 2024 | |
| Endo USA, INC. | $146.63 | 2024 | Xiaflex |
| Axonics, INC. | $140.64 | 2023 | Bulkamid |
| Medtronic, INC. | $121.43 | 2024 | Interstim |
| Ambu INC. | $119.49 | 2025 | |
| Baxter Healthcare | $116.67 | 2025 | |
| Abbvie INC. | $111.50 | 2023 | |
| Calyxo, INC. | $105.32 | 2025 | Cvac Aspiration System |
| Karl Storz Endoscopy-America | $87.61 | 2022 | |
| Photocure INC | $47.73 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $47.03 | 2025 | Illuccix |
| Antares Pharma, INC. | $18.40 | 2025 | Xyosted |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Pierce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.